Related Experiment Videos
Neutrophilic fixed drug eruption.
1Department of Dermatology, Green Lane Hospital, Auckland, New Zealand.
The Australasian Journal of Dermatology
|August 8, 2001
Summary
A man developed a fixed drug eruption from amoxicillin-clavulanic acid. Histopathology revealed a neutrophilic dermatosis, suggesting a new condition: neutrophilic fixed drug eruption.
Area of Science:
- Dermatology
- Pharmacology
- Histopathology
Background:
- Fixed drug eruptions are a common cutaneous adverse drug reaction.
- Neutrophilic dermatoses are inflammatory conditions characterized by neutrophil infiltration.
Observation:
- A 49-year-old male presented with a recurrent, localized rash after amoxicillin-clavulanic acid administration.
- Skin biopsy of the affected area showed a neutrophilic dermatosis.
Findings:
- The histopathological findings of neutrophilic dermatosis in a fixed drug eruption are novel.
- This case challenges the typical understanding of fixed drug eruption pathology.
Implications:
- The findings suggest a potential new clinical entity: neutrophilic fixed drug eruption.
- This may necessitate re-evaluation of diagnostic criteria and treatment approaches for certain drug-induced eruptions.